Firebrick Pharma Limited (ASX:FRE)

Firebrick Pharma Statistics

Total Valuation

ASX:FRE has a market cap or net worth of AUD 13.02 million. The enterprise value is 12.04 million.

Market Cap	13.02M
Enterprise Value	12.04M

Important Dates

The last earnings date was Thursday, December 4, 2025.

Earnings Date	Dec 4, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:FRE has 250.37 million shares outstanding. The number of shares has increased by 17.46% in one year.

Current Share Class	250.37M
Shares Outstanding	250.37M
Shares Change (YoY)	+17.46%
Shares Change (QoQ)	+8.54%
Owned by Insiders (%)	32.37%
Owned by Institutions (%)	n/a
Float	126.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.26
PB Ratio	8.37
P/TBV Ratio	8.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.57
EV / Sales	23.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.46

Financial Position

The company has a current ratio of 5.47

Current Ratio	5.47
Quick Ratio	4.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -143.50% and return on invested capital (ROIC) is -86.45%.

Return on Equity (ROE)	-143.50%
Return on Assets (ROA)	-74.97%
Return on Invested Capital (ROIC)	-86.45%
Return on Capital Employed (ROCE)	-163.16%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	0.87

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.45% in the last 52 weeks. The beta is 1.35, so ASX:FRE's price volatility has been higher than the market average.

Beta (5Y)	1.35
52-Week Price Change	-5.45%
50-Day Moving Average	0.06
200-Day Moving Average	0.07
Relative Strength Index (RSI)	31.72
Average Volume (20 Days)	142,143

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:FRE had revenue of AUD 515,507 and -2.63 million in losses. Loss per share was -0.01.

Revenue	515,507
Gross Profit	326,902
Operating Income	-2.54M
Pretax Income	-2.63M
Net Income	-2.63M
EBITDA	-2.53M
EBIT	-2.54M
Loss Per Share	-0.01

Balance Sheet

The company has 983,350 in cash and n/a in debt, giving a net cash position of 983,350 or 0.00 per share.

Cash & Cash Equivalents	983,350
Total Debt	n/a
Net Cash	983,350
Net Cash Per Share	0.00
Equity (Book Value)	1.56M
Book Value Per Share	0.01
Working Capital	1.21M

Cash Flow

In the last 12 months, operating cash flow was -1.78 million and capital expenditures -82,979, giving a free cash flow of -1.86 million.

Operating Cash Flow	-1.78M
Capital Expenditures	-82,979
Free Cash Flow	-1.86M
FCF Per Share	-0.01

Margins

Gross Margin	63.41%
Operating Margin	-492.61%
Pretax Margin	-511.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:FRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.46%
Shareholder Yield	-17.46%
Earnings Yield	-20.23%
FCF Yield	-14.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:FRE has an Altman Z-Score of 13.01 and a Piotroski F-Score of 2.

Altman Z-Score	13.01
Piotroski F-Score	2